Cerca un farmaco orfano
Altra/e opzione/i di ricerca
47 Risultato/i
Sostanza(e)
- (S)-3-(1-(9H-purin-6-ylammino)etil)-8-cloro-2-fenilisochinolino-1(2H)-one
- 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
- 17-(allylamino)-17-demethoxygeldanamycin, hydroquinone, hydrochloride
- 68Ga-DOTA-pABzA-DIG-dPhe-Gln-Trp-Ala-Val-Gly-His-NHCHCH2-CHCH322
- A live attenuated bioengineered Listeria monocytogenes cancer immunotherapy
- Alisertib
- Anagrelide
- Anticorpo monoclonale anti-CD30 umano legato in modo covalente alla citotossina monometilauristatina E
- Belinostat
- Bezuclastinib
- Darinaparsin
- Fenretinide
- Ilixadencel
- Imatinib mesilato
- Inhibitor of primary and secondary KIT and PDGFR alpha kinase mutants found in GIST
- Ittrio (90Y) edotreotide
- Ligand binding moiety to STAT3, a chemical linker, and a ligand binding moiety to an E3 ligase that leads to STAT3 degradation
- Mogamulizumab
- N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide
- N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
- Nanatinostat, valganciclovir
- Nilotinib
- Olverembatinib
- Ponatinib
- Pralatrexato
- Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein
- Regorafenib
- Retifanlimab
- Romidepsin
- Small Molecule Inhibitor of Exon 17 mutant KIT
- Small-molecule oral KIT inhibitor targeting activating mutations and resistance mutations
- Sunitinib
- Zanolimumab
- [4-(Methyl-1H-pyrazol-4-yl)-benzyl] -(6-[7-(3-pyrrolidin-1-yl-propoxy)-imidazo[1,2-a] pyridin-3-yl]-pyrimidin-4-yl]-amine